5-[(4-Methylphenyl)methyl]-7-(trifluoromethyl)-1H,3H,3aH,4H,5H-[1,3]thiazolo[3,4-a]quinoxalin-4-one

Catalog No. :
ACLSWO676
CAS No. :
1024019-81-5
Molecular Formula :
C19H17F3N2OS
Molecular Weight :
378.42

IUPAC Name:5-(4-methylbenzyl)-7-(trifluoromethyl)-3,3a-dihydro-1H-thiazolo[3,4-a]quinoxalin-4(5H)-one

5-[(4-Methylphenyl)methyl]-7-(trifluoromethyl)-1H,3H,3aH,4H,5H-[1,3]thiazolo[3,4-a]quinoxalin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-[(4-Methylphenyl)methyl]-7-(trifluoromethyl)-1H,3H,3aH,4H,5H-[1,3]thiazolo[3,4-a]quinoxalin-4-one
IUPAC Name5-(4-methylbenzyl)-7-(trifluoromethyl)-3,3a-dihydro-1H-thiazolo[3,4-a]quinoxalin-4(5H)-one
MDL No.MFCD04124962
Molecular FormulaC19H17F3N2OS
Molecular Weight378.42
SMILESO=C1C2N(CSC2)C3=C(C=C(C(F)(F)F)C=C3)N1CC4=CC=C(C)C=C4
InChI KeyWVUFPZZDAJWELK-UHFFFAOYSA-N
Synonym5-(4-METHYLBENZYL)-7-(TRIFLUOROMETHYL)-3,3A-DIHYDRO[1,3]THIAZOLO[3,4-A]QUINOXALIN-4(5H)-ONE;5-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-1H,3H,3aH,4H,5H-[1,3]thiazolo[3,4-a]quinoxalin-4-one;1H-Thiazolo[3,4-a]quinoxalin-4(5H)-one, 3,3a-dihydro-5-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-
CAS No.1024019-81-5

Synthetic Route by SureRoute

1. ACLSWO676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSWO676 route product structure diagram
    ACLSWO6761024019-81-5
Inquiry

2. ACLSWO676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSWO676 route product structure diagram
    ACLSWO6761024019-81-5
Inquiry

Comments (0)